• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A decade of R-CHOP.

作者信息

Sehn Laurie H

机构信息

British Columbia Cancer Agency.

出版信息

Blood. 2010 Sep 23;116(12):2000-1. doi: 10.1182/blood-2010-07-293407.

DOI:10.1182/blood-2010-07-293407
PMID:20864584
Abstract
摘要

相似文献

1
A decade of R-CHOP.利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松方案的十年应用
Blood. 2010 Sep 23;116(12):2000-1. doi: 10.1182/blood-2010-07-293407.
2
Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.接受CHOP和利妥昔单抗-CHOP化疗的B细胞非霍奇金淋巴瘤患者轻度认知障碍的早期表现
Naunyn Schmiedebergs Arch Pharmacol. 2016 Dec;389(12):1253-1265. doi: 10.1007/s00210-016-1290-y. Epub 2016 Aug 27.
3
Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma.老年弥漫性大B细胞淋巴瘤患者R-CHOP疗法的演变
Expert Rev Anticancer Ther. 2008 Oct;8(10):1651-8. doi: 10.1586/14737140.8.10.1651.
4
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth.利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松（R-CHOP）化疗用于治疗妊娠期弥漫性大B细胞淋巴瘤可能与早产有关。
Obstet Gynecol Sci. 2014 Nov;57(6):526-9. doi: 10.5468/ogs.2014.57.6.526. Epub 2014 Nov 20.
5
R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma.R-分割CHOP化疗用于老年弥漫性大B细胞淋巴瘤患者。
Eur J Haematol. 2014 Jul;93(1):70-6. doi: 10.1111/ejh.12304. Epub 2014 Mar 28.
6
Comparison of therapeutic outcomes between surgical resection followed by R-CHOP and R-CHOP alone for localized primary intestinal diffuse large B-cell lymphoma.局限性原发性肠道弥漫性大B细胞淋巴瘤手术切除后序贯R-CHOP方案与单纯R-CHOP方案治疗效果的比较。
Am J Clin Oncol. 2014 Apr;37(2):182-7. doi: 10.1097/COC.0b013e318271b125.
7
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).与利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松龙相比，利妥昔单抗、环磷酰胺、非聚乙二醇化脂质体阿霉素、长春新碱和泼尼松龙在弥漫性大B细胞淋巴瘤患者一线治疗中的心脏毒性：奥地利癌症药物治疗工作组[Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14)的一项随机III期研究。
Eur J Cancer. 2016 May;58:112-21. doi: 10.1016/j.ejca.2016.02.004. Epub 2016 Mar 15.
8
R-CHOP therapy alone for limited-stage follicular lymphoma.单纯R-CHOP方案治疗局限期滤泡性淋巴瘤。
Leuk Res. 2015 Jun;39(6):582-5. doi: 10.1016/j.leukres.2015.03.008. Epub 2015 Apr 6.
9
Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma.局限期弥漫性大B细胞淋巴瘤经R-CHOP化疗后受累野放射治疗的额外生存获益
Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):91-8. doi: 10.1016/j.ijrobp.2014.12.042. Epub 2015 Feb 24.
10
[Efficacy and safety of rituximab combined with CHOP or combined with dose fractionated CHOP in the treatment of primary gastric diffuse large B cell lymphoma].利妥昔单抗联合CHOP或联合剂量分割CHOP治疗原发性胃弥漫性大B细胞淋巴瘤的疗效和安全性
Zhonghua Zhong Liu Za Zhi. 2014 Dec;36(12):939-43.

引用本文的文献

1
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study.年龄是弥漫性大B细胞淋巴瘤患者实现24个月无事件生存的最重要生存预测因素：一项基于瑞典人群的研究。
Br J Haematol. 2021 Jun;193(5):906-914. doi: 10.1111/bjh.17206. Epub 2021 May 5.
2
Impact of Double Expression of C-MYC/BCL2 Protein and Cell of Origin Subtypes on the Outcome among Patients with Diffuse Large B-Cell Lymphoma: a Single Asian Center Experience.C-MYC/BCL2蛋白双表达及起源细胞亚型对弥漫性大B细胞淋巴瘤患者预后的影响：一项亚洲单中心经验
Asian Pac J Cancer Prev. 2018 May 26;19(5):1229-1236. doi: 10.22034/APJCP.2018.19.5.1229.
3
Anticancer Activity of Ganoderic Acid DM: Current Status and Future Perspective.
灵芝酸DM的抗癌活性：现状与未来展望
J Clin Cell Immunol. 2017;8(6). doi: 10.4172/2155-9899.1000535. Epub 2017 Dec 12.
4
Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.类脂纳米颗粒介导的Mcl-1基因沉默诱导套细胞淋巴瘤细胞凋亡。
Exp Biol Med (Maywood). 2016 May;241(9):1007-13. doi: 10.1177/1535370216640944. Epub 2016 Mar 27.
5
Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment.组成型雄烷受体的激活增加了CHOP在淋巴瘤治疗中的治疗指数。
Mol Cancer Ther. 2016 Mar;15(3):392-401. doi: 10.1158/1535-7163.MCT-15-0667. Epub 2016 Jan 28.
6
Chemical profiling of the genome with anti-cancer drugs defines target specificities.用抗癌药物进行基因组化学剖析可确定药物的靶标特异性。
Nat Chem Biol. 2015 Jul;11(7):472-80. doi: 10.1038/nchembio.1811. Epub 2015 May 11.
7
Receptor tyrosine kinases MET and RON as prognostic factors in diffuse large B-cell lymphoma patients receiving R-CHOP.受体酪氨酸激酶 MET 和 RON 作为接受 R-CHOP 治疗的弥漫性大 B 细胞淋巴瘤患者的预后因素。
Cancer Sci. 2013 Sep;104(9):1245-51. doi: 10.1111/cas.12215. Epub 2013 Jul 11.